Oregon 2025R1 Session Status: In Committee

HB 3017 — Requires the Oregon Health Authority to study the risks to human health of chemicals in menstrual, intimate care and incontinence products.

Last action — In House Committee

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced January 28, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Stalled 14% · moderate confidence

  • In Committee

    Current position in the legislative process.

  • 1 sponsor

    1 primary, 0 co-sponsors signed on.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

Digest: The Act would tell OHA to study the risks to human health of chemicals in some products. (Flesch Readability Score: 75.1). Requires the Oregon Health Authority to study the risks to human health of chemicals in menstrual, intimate care and incontinence products. Directs the authority to submit findings to the interim committees of the Legislative Assembly related to public health no later than September 15, 2026. Sunsets on January 2, 2027.

Bill Text

We don't have the full text on file for this bill yet.

Read HB 3017 on the official Oregon source →

Action History

  1. In House Committee

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 89 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (89)

89 members have not signed on to this bill.

Show all 89 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 3017 do?
Digest: The Act would tell OHA to study the risks to human health of chemicals in some products. (Flesch Readability Score: 75.1). Requires the Oregon Health Authority to study the risks to human health of chemicals in menstrual, intimate care and incontinence products. Directs the authority to submit findings to the interim committees of the Legislative Assembly related to public health no later than September 15, 2026. Sunsets on January 2, 2027.
Who sponsors HB 3017?
HB 3017 is sponsored by Courtney Neron.
What is the current status of HB 3017?
This bill is in committee in the House. Introduced January 28, 2025. It must pass committee before a floor vote.
Where can I track HB 3017?
Track HB 3017 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 3017

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB 3017

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →